HCPCS Code C9093
Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
| Short Description | Inj., susvimo, 0.1 mg |
|---|---|
| Year | 2026 |
| Coverage Code | D = Special coverage instructions apply |
| Action Code | N = No maintenance for this code |
| Action Effective Date | July 01, 2022 |
| Code Added Date | April 01, 2022 |
| Pricing Indicator | 53 = Statute |
| Type of Service | 9 = Other medical items or services |